Extraintestinal helminth infection limits pathology and proinflammatory cytokine expression during DSS-induced ulcerative colitis: A role for alternatively activated macrophages and prostaglandins

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Ledesma Soto, Yadira ^a   Callejas, Blanca E ^a   Terrazas, César A ^b   Reyes, Jose L ^c   Espinoza Jiménez, Arlett ^a   González, Marisol I ^a   León Cabrera, Sonia ^a   Morales, Rosario ^a   Olguín, Jonadab E ^d   Saavedra, Rafael ^d   Oghumu, Steve ^b   Satoskar, Abhay R ^b   Terrazas, Luis I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DEXTRAN SULFATE; FIZZ 1 PROTIEN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 4; MESSENGER RNA; PROSTAGLANDIN E2; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YM 1 PROTEIN; ARGINASE; ARGINASE I, HUMAN; IL10 PROTEIN, HUMAN; NOS2 PROTEIN, HUMAN; PROSTAGLANDIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EXTRAINTESTINAL HELMINTH INFECTION; FEMALE; FLOW CYTOMETRY; GOBLET CELL; HELMINTHIASIS; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; INTESTINE INFECTION; LAMINA PROPRIA; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAENIASIS; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; COMPLICATION; CROHN DISEASE; DISEASE MODEL; GENETICS; HUMAN; INFLAMMATION; INTESTINE MUCOSA; MACROPHAGE; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; TAENIA;

MUS; TAENIA; TAENIA CRASSICEPS; VERMES;

ANIMALS; ARGINASE; COLITIS, ULCERATIVE; CROHN DISEASE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-4; INTESTINAL MUCOSA; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDINS; TAENIA; TAENIASIS;

EID: 84930614300     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/563425     Document Type: Article

References (46)

1. J. E. Allen and R. M.Maizels, "Diversity and dialogue in immunity to helminths," Nature Reviews Immunology, vol. 11, no. 6, pp. 375-388, 2011.
2. K. J. Mylonas, M. A. Hoeve, A. S. MacDonald, and J. E. Allen, "Alternative activation of macrophages by filarial nematodes is MyD88-independent," Immunobiology, vol. 218, no. 4, pp. 570-578, 2013.
3. R. M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M. D. Taylor, and J. E. Allen, "Helminth parasites-masters of regulation," Immunological Reviews, vol. 201, pp. 89-116, 2004.
4. D. E. Elliott and J. V. Weinstock, "Helminth-host immunological interactions: prevention and control of immune-mediated diseases," Annals of the New York Academy of Sciences, vol. 1247, no. 1, pp. 83-96, 2012.
5. M. D. Kappelman, S. L. Rifas-Shiman, K. Kleinman et al., "The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States," Clinical Gastroenterology and Hepatology, vol. 5, no. 12, pp. 1424-1429, 2007.
6. J. Burisch, T. Jess,M.Martinato, and P. L. Lakatos, "The burden of inflammatory bowel disease in Europe," Journal of Crohn's and Colitis, vol. 7, no. 4, pp. 322-337, 2013.
7. V. Valatas,M. Vakas, and G. Kolios, "The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases," American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 305, no. 11, pp. G763-G785, 2013.
8. K. Donskow-Lysoniewska, P. Majewski, K. Brodaczewska, K. Jóźwicka, and M. Doligalska, "Heligmosmoides polygyrus fourth stages induce protection against DSS-induced colitis and change opioid expression in the intestine," Parasite Immunology, vol. 34, no. 11, pp. 536-546, 2012.
9. A. Melon, A. Wang, V. Phan, and D. M. McKay, "Infection withHymenolepis diminuta ismore effective than daily corticosteroids in blocking chemically induced colitis in mice," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 384523, 7 pages, 2010.
10. N. A. Braus and D. E. Elliott, "Advances in the pathogenesis and treatment of IBD," Clinical Immunology, vol. 132, no. 1, pp. 1-9, 2009.
11. J. V. Weinstock and D. E. Elliott, "Helminths and the IBD hygiene hypothesis," Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 128-133, 2009.
12. R. W. Summers, D. E. Elliott, J. F. Urban Jr., R. A. Thompson, and J. V.Weinstock, "Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial,"Gastroenterology, vol. 128, no. 4, pp. 825-832, 2005.
13. A. Wang, M. Fernando, G. Leung, V. Phan, D. Smyth, and D. M.McKay, "Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils," The American Journal of Pathology, vol. 177, no. 6, pp. 2850-2859, 2010.
14. M. Heylen, N. E. Ruyssers, E. M. Gielis et al., "Of worms, mice and man: an overview of experimental and clinical helminthbased therapy for inflammatory bowel disease," Pharmacology & Therapeutics, vol. 143, no. 2, pp. 153-167, 2014.
15. H. J. van Kruiningen and A. B. West, "Potential danger in the medical use of Trichuris suis for the treatment of inflammatory bowel disease," Inflammatory BowelDiseases, vol. 11,no. 5, p. 515, 2005.
16. A. N. Peón, A. Espinoza-Jiménez, and L. I. Terrazas, "Immunoregulation by Taenia crassiceps and its antigens," BioMed Research International, vol. 2013, Article ID 498583, 13 pages, 2013.
17. A. Espinoza-Jiménez, I. Rivera-Montoya, R. Cárdenas-Arreola, L. Morán, and L. I. Terrazas, "Taenia crassiceps infection attenuatesmultiple low-dose streptozotocin-induced diabetes," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 850541, 11 pages, 2010.
18. J. L. Reyes, A. F. Espinoza-Jiménez, M. I. González, L. Verdin, and L. I. Terrazas, "Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis," Cellular Immunology, vol. 267, no. 2, pp. 77-87, 2011.
19. A. M. Ortiz-Flores, Y. Ledesma-Soto, E. A. Calleja, M. Rodr íguez-Sosa, I. Juárez, and L. I. Terrazas, "Taenia crassiceps infection does not influence the development of experimental rheumatoid arthritis," BioMed Research International, vol. 2013, Article ID 316980, 9 pages, 2013.
20. C. E.Matisz, J. J. McDougall, K. A. Sharkey, and D.M.McKay, "Helminth parasites and themodulation of joint inflammation," Journal of Parasitology Research, vol. 2011, Article ID 942616, 8 pages, 2011.
21. J. H. Niess and S. Danese, "Anti-TNF and skin inflammation in IBD: A new paradox in gastroenterology?" Gut, vol. 63,no. 4, pp. 533-535, 2014.
22. F.Tao,C.Qian,W. Guo, Q. Luo, Q. Xu, andY. Sun, "Inhibitionof Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin," Biochemical Pharmacology, vol. 85, no. 6, pp. 798-807, 2013.
23. X. Yang, Y. Yang, Y.Wang et al., "Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice," PLoS ONE, vol. 9, no. 5,Article IDe96454, 2014.
24. J. Leung, L. Hang, A. Blum, T. Setiawan, K. Stoyanoff, and J. Weinstock, "Heligmosomoides polygyrus abrogates antigenspecific gut injury in a murine model of inflammatory bowel disease," Inflammatory Bowel Diseases, vol. 18, no. 8, pp. 1447-1455, 2012.
25. H.-M. Mo, W.-Q. Liu, J.-H. Lei, Y.-L. Cheng, C.-Z. Wang, and Y.-L. Li, "Schistosoma japonicum eggs modulate the activity of CD4+ CD25+ Tregs and prevent development of colitis in mice," Experimental Parasitology, vol. 116, no. 4, pp. 385-389, 2007.
26. L. Hang, A. M. Blum, T. Setiawan, J. P. Urban Jr., K. M. Stoyanoff, and J. V. Weinstock, "Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis," The Journal of Immunology, vol. 191, no. 4, pp. 1927-1934, 2013.
27. V. B. L. Moura, M. M. Silva, L. F. Batista et al., "Arginase activity is associated with fibrosis in experimental infection with Taenia crassiceps, but does not play a major role in resistance to infection," Experimental Parasitology, vol. 135, no. 3, pp. 599-605, 2013.
28. L. I. Terrazas, D. Montero, C. A. Terrazas, J. L. Reyes, and M. Rodríguez-Sosa, "Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis," International Journal for Parasitology, vol. 35, no. 13, pp. 1349-1358, 2005.
29. M. Rodríguez-Sosa, A. R. Satoskar, R. Calderón et al., "Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability," Infection and Immunity, vol. 70, no. 7, pp. 3656-3664, 2002.
30. T. Chinen, K. Komai, G. Muto et al., "Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance," Nature Communications, vol. 2, no. 1, article 190, 2011.
31. J. Burisch,N. Pedersen, S.Cukovic-Cavka et al., "Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe-an ECCO-EpiCom study," Journal of Crohn's and Colitis, vol. 8, no. 7, pp. 607-616, 2014.
32. L. Adalid-Peralta, G. Fragoso, A. Fleury, and E. Sciutto, "Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections," International Journal of Biological Sciences, vol. 7, no. 9, pp. 1412-1426, 2011.
33. K. Yasukawa, H. Tokuda, X. Tun, H. Utsumi, and K.-I. Yamada, "The detrimental effect of nitric oxide on tissue is associated with infl ammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis," Free Radical Research, vol. 46, no. 12, pp. 1427-1436, 2012.
34. M. Yamagata, T.Mikami, T. Tsuruta et al., "Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis," Digestion, vol. 84, no. 1, pp. 12-21, 2011.
35. C. C. Bain and A.M.Mowat, "Macrophages in intestinal homeostasis and inflammation," Immunological Reviews, vol. 260, no. 1, pp. 102-117, 2014.
36. C. C. Bain and A. M. Mowat, "The monocyte-macrophage axis in the intestine," Cellular Immunology, vol. 291, no. 1-2, pp. 41-48, 2014.
37. Y.Takada, T. Hisamatsu, N. Kamada et al., "Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset," The Journal of Immunology, vol. 184, no. 5, pp. 2671-2676, 2010.
38. Y. S. Bao, P. Zhang, R. J. Xie et al., "The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2," International Immunopharmacology, vol. 11, no. 10, pp. 1599-1605, 2011.
39. D. E. Elliott, T. Setiawan, A. Metwali, A. Blum, J. F. Urban Jr., and J. V. Weinstock, "Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice," European Journal of Immunology, vol. 34, no. 10, pp. 2690-2698, 2004.
40. S. Koyasu and K. Moro, "Type 2 innate immune responses and the natural helper cell," Immunology, vol. 132, no. 4, pp. 475-481, 2011.
41. S. Leon-Cabrera, M. Cruz-Rivera, F. Mendlovic et al., "Immunological mechanisms involved in the protection against intestinal taeniosis elicited by oral immunization with Taenia solium calreticulin," Experimental Parasitology, vol. 132, no. 3, pp. 334-340, 2012.
42. Y.Kurashima,Y.Goto, and H.Kiyono, "Mucosal innateimmune cells regulate both gut homeostasis and intestinal inflammation," European Journal of Immunology, vol. 43, no. 12, pp. 3108-3115, 2013.
43. M. van der Sluis, B. A. E. de Koning, A. C. J. M. de Bruijn et al., "Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection," Gastroenterology, vol. 131, no. 1, pp. 117-129, 2006.
44. X. O. Yang, S. H. Chang, H. Park et al., "Regulation of inflammatory responses by IL-17F,"The Journal of ExperimentalMedicine, vol. 205, no. 5, pp. 1063-1075, 2008.
45. C. Tang and Y. Iwakura, "IL-23 in Colitis: targeting the Progenitors," Immunity, vol. 37, no. 6, pp. 957-959, 2012.
46. M. Becerra-Díaz and L. I. Terrazas, "Taenia crassiceps infection and its excreted/secreted products inhibit STAT1 activation in response to IFN," International Journal for Parasitology, vol. 44, no. 9, pp. 613-623, 2014.